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Abstract

Introduction: Memory deficits characterize Alzheimer’s dementia and the clinical precursor stage
known as mild cognitive impairment. Nonpharmacologic interventions hold promise for enhancing
functioning in these patients, potentially delaying functional impairment that denotes transition to
dementia. Previous findings revealed that mnemonic strategy training (MST) enhances long-term
retention of trained stimuli and is accompanied by increased blood oxygen level–dependent signal
in the lateral frontal and parietal cortices as well as in the hippocampus. The present study was
designed to enhance MST generalization, and the range of patients who benefit, via concurrent
delivery of transcranial direct current stimulation (tDCS).
Methods: This protocol describes a prospective, randomized controlled, four-arm, double-blind
study targeting memory deficits in those with mild cognitive impairment. Once randomized, participants complete five consecutive daily sessions in which they receive either active or sham high definition tDCS over the left lateral prefrontal cortex, a region known to be important for successful
memory encoding and that has been engaged by MST. High definition tDCS (active or sham) will
be combined with either MST or autobiographical memory recall (comparable to reminiscence
therapy). Participants undergo memory testing using ecologically relevant measures and functional
magnetic resonance imaging before and after these treatment sessions as well as at a 3-month
follow-up. Primary outcome measures include face-name and object-location association tasks.
Secondary outcome measures include self-report of memory abilities as well as a spatial navigation
task (near transfer) and prose memory (medication instructions; far transfer). Changes in functional
magnetic resonance imaging will be evaluated during both task performance and the resting-state
using activation and connectivity analyses.
Discussion: The results will provide important information about the efficacy of cognitive and
neuromodulatory techniques as well as the synergistic interaction between these promising
approaches. Exploratory results will examine patient characteristics that affect treatment efficacy,
thereby identifying those most appropriate for intervention.
Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Trial status: The study is actively enrolling participants.
Trial Registration: www.clinicaltrials.gov: NCT02155946 (Registered
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1. Introduction
It is well known that the proportion of older adults is
increasing within both the United States and globally.
Alzheimer’s disease is the most common cause of dementia
(i.e., Alzheimer’s dementia—AD) with a rate of about 9.5%
in those for more than age 70 years; this rate is expected to
increase twofold to threefold in the coming decades [1,2].
Delaying conversion to AD will not only improve patient
quality of life but may also reduce the financial costs of
the disease. The diagnosis of mild cognitive impairment
(MCI) captures those who are cognitively symptomatic
and at high risk of conversion to AD, yet demonstrate
relatively preserved everyday functioning [3–5]. Learning
and memory deficits are the most common presenting
problem [3,5] and are associated with medial temporal
lobe atrophy and dysfunction [5–7]. Associative memory
paradigms may be especially sensitive to early decline
given their reliance on medial temporal lobe structures
[8]. In fact, patients with MCI demonstrate deficits on
ecologically relevant associative tasks such as face-name
[9] and object-location associations [10], which are accompanied by hypoactivation of key lateral frontoparietal and
medial temporal regions relative to control subjects [10].
The lateral frontoparietal network (i.e., middle and inferior
frontal gyri, inferior frontal sulcus, and intraparietal sulcus)
is known to be important in successful memory formation
[11], possibly because of its role in mediating working
memory [12–14]. We further supported the importance of
this network using effective connectivity analyses, which
revealed that cognitively intact older adults engaged the
left frontoparietal network during the successful encoding
of new object-location associations [15]. In contrast, MCI
patients engaged the right frontal eye field, a region known
to mediate basic attentional saccades. Together, these findings suggest that memory deficits in patients with MCI may
emerge through a combined “loss” of medial temporal and
frontoparietal functioning.
The critical question is how to enhance or otherwise
maximize memory in those with MCI, especially considering the limited cognitive effects of existing pharmacologic
agents [16–18]. The current, ongoing, double-blind,
randomized controlled trial addresses this question using
two promising nonpharmacologic approaches: mnemonic
strategy training (MST) and transcranial direct current
stimulation (tDCS).
As we previously described [19,20], MST teaches
participants to use cognitive “tools” that enhance the
organization of information while also requiring patients
to process information more deeply, factors known to
enhance memory [21,22]. We demonstrated that MST

enhances memory for face-name [23] and object-location
associations [19] and others have found comparable benefits for tasks such as word lists [24]. These behavioral improvements were accompanied by increased activation in
regions of the lateral frontoparietal network [24,25] and
the hippocampus [26]. Together, these findings suggest
that MST may enhance memory by re-engaging these previously dysfunctional brain regions/networks. However,
our prior data indicate two potential limitations. First,
MST appears less effective in patients with “late” MCI
(i.e., those closer to developing AD) than “early” MCI
(i.e., those closer to “normal”) [19,23]. Second, patients
have difficulty spontaneously transferring MST to novel
types of information, a common problem in this area of
research.
We selected tDCS as a potential method for overcoming
these limitations. tDCS modulates neuronal excitability by
passing a weak electric current between electrodes that are
placed on the scalp. Traditionally, tDCS uses two electrodes (usually 25–35 cm2): an anode that “introduces”
the electrical current and a cathode that “collects” the
current. Evidence suggests that neuronal somata under
the anode become depolarized [27]. Thus, tDCS does not
directly induce neuronal firing but, rather, produces conditions that make firing more or less likely to occur. To
enhance focality, we are using high definition (HD)
tDCS. This method uses a 4 ! 1 ring configuration in
which the central electrode is surrounded by four electrodes
of the opposite polarity [28,29]. Practically, this means that
the “ring” electrodes each use about ¼ of the electrical
current, whereas the central electrode uses the full
amount. This approach limits the cortical modulation
effects to the area of the four-electrode ring (see [29])
and presumably minimizes the confounding physiological
effects of the ring electrodes. Applied to the motor cortex,
HD-tDCS induces greater and more persistent neuromodulatory effects than the traditional approach [30] while
remaining well tolerated and without significant side
effects (see [28,31]).
We believe the combined use of MST and HD-tDCS is
especially appropriate because there is evidence that concurrent tDCS and training enhances consolidation of the trained
skill (see [32]). We target the left lateral prefrontal cortex
(PFC) given its importance in successful learning and in
mnemonic strategy use (as described previously). Thus, we
are particularly interested in the synergistic effects of
combined MST and HD-tDCS. The current trial randomizes
participants to one of four treatment groups that consist of
MST or an autobiographical memory recall (ABR) in
combination with active or sham HD-tDCS.

B.M. Hampstead et al. / Alzheimer’s & Dementia: Translational Research & Clinical Interventions 3 (2017) 459-470

The primary objectives of the study are as follows:
(1) Examine the cognitive benefits of the interventions
using ecologically relevant outcome measures. We
predict main effects of group where MST is more
effective than ABR and active HD-tDCS is more
effective than sham HD-tDCS. Our primary interest,
however, is in the cognitive by stimulation group
interaction where we expect the greatest benefits of
combined MST 1 active HD-tDCS and least (if
any) improvement in ABR 1 sham HD-tDCS.
Persistent gains are predicted to be most likely in
the combined MST 1 active HD-tDCS group.
(2) Use functional magnetic resonance imaging (fMRI) to
evaluate the neuroplastic/neurophysiological changes
associated with intervention. We predict main effects
of group where the MST and active HD-tDCS groups
will demonstrate greater (ventro)lateral PFC activation than the ABR and sham HD-tDCS groups. The
cognitive by stimulation group interaction is again of
particular interest and should mirror the behavioral
changes in Aim 1. An intriguing alternative outcome
of reduced activation within the context of improved
behavioral performance (analogous to a repetition
suppression fMRI effect) would suggest increased
processing efficiency.
Exploratory analyses will examine treatment effects on
working memory and semantic processing. The targeted
left ventrolateral PFC plays an important role in working
memory, semantic processing, and successful memory
encoding, all of which may be enhanced by active HDtDCS over this region. These effects will be evaluated via
behavioral performance and fMRI with the expectation of
a main effect of stimulation (active . sham) but not necessarily a cognitive training group (given the targeted nature of
MST) or interaction effect.
2. Methods
This is a double-blind, randomized controlled trial with
parallel groups allocated 1:1:1:1 using a superiority framework. After an initial consent/screening session, participants
complete seven sessions within approximately 2 weeks and
an eighth session at the 3-month time point. Participants
undergo fMRI during sessions 1, 7, and 8 as well as intervening training during five consecutive daily sessions (Sessions 2–6). Behavioral outcome measures are evaluated at
baseline/Session 1, Session 6 (after training), and Session
8. The study timeline is shown in Fig. 1.
2.1. Participants
We intend to recruit 100 right-handed participants, age
50 years and older, who hold a diagnosis of MCI. Participants
are drawn from the VA Ann Arbor Healthcare System, the
University of Michigan Alzheimer’s Disease Core Center
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and associated participant registries, and the surrounding
community. Inclusion criteria: patients will have a diagnosis
of MCI based on the Albert et al. [5] criteria. Specifically,
patients will (1) report a subjective decline in memory (report
can also be provided by an informant or clinician), (2) demonstrate objective impairment in memory (based on neuropsychological testing), and (3) remain generally independent in
activities of daily living. All patients will be stable on medications for at least 1 month before study initiation. Exclusion
criteria: a history of (1) other neurologic (e.g., epilepsy, moderate to severe traumatic brain injury) or medical conditions
that are known to affect cognitive functioning and that are
considered primary to cognitive decline; (2) significant
psychiatric conditions (e.g., moderate to severe depression,
bipolar disorder, schizophrenia); (3) sensory impairments
that limit the ability to take part in the study; and (4) current
alcohol or other drug abuse/dependence. Participants are also
screened to ensure MRI and HD-tDCS compatibility. Eligible
participants who cannot undergo MRI will be enrolled in the
study and will complete only the stimulation and behavioral
portions of the study (including outcome evaluations) within
a quiet office setting. Enrollment is open to participants
regardless of race, gender, or social status.
2.2. Baseline evaluations
After providing informed, written consent obtained by a
study team member, participants undergo a brief neuropsychological protocol that includes the Montreal Cognitive
Assessment [33], Wechsler Test of Adult Reading [34],
Repeatable Battery for the Assessment of Neuropsychological Status [35], Emory short version of the Wisconsin Card
Sorting Test [36], Trail Making Test [37], Geriatric Depression Scale [38], and Functional Activities Questionnaire
[39]. This protocol ensures patients continue to meet criteria
for MCI and also characterizes their cognitive functioning at
the time of enrollment, which are important given the lag
that may occur between diagnosis and study entry. Primary
and secondary outcome measures are collected during this
initial session but are not used to determine inclusion.
2.3. Primary outcome measures
Primary outcome measures include two internally developed memory tests that are meant to emulate real-world
difficulties that patients with MCI experience. We designed
these measures to adhere to common parameters used in
clinically based tests to facilitate comparison with the wider
area of research. Both these tasks have three versions that are
comparable based on a number of critical features.
Mnemonic strategies require time to implement (see discussion of important methodological factors in [22]), so both
tasks provide 15-second exposures for each of 15 associations. Memory for these stimuli is evaluated after a 15minute delay. Recognition foils are actual target stimuli
(i.e., targets that were incorrectly paired with the face or
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STUDY PERIOD
Post-allocation
Baseline
ENROLLMENT:

X

Eligibility screen

X

Informed consent

X

Neuropsychological Testing

X

fMRI Scanning & associated
tests
Primary outcome measures
FNGT
OLTT
Secondary outcome measures
MMQ
EMS-Route Recall
EMS Medical Instructions

S1

S2

S3-5

S6

X

S7

S8
(3-month f/u)

X

X

X

X

X

X

X

X

Allocation/Randomization

X

MST+ active HD-tDCS

X

X

X

MST + sham HD-tDCS

X

X

X

ABR + active HD-tDCS

X

X

X

ABR + sham HD-tDCS

X

X

X

Fig. 1. Schedule of enrollment, interventions, and assessments. Abbreviations: ABR, autobiographical memory recall; EMS, ecological memory simulations;
fMRI, functional magnetic resonance imaging; FNGT, face-name generalization task; OLTT, Object Location Touchscreen Test; HD-tDCS, high definition
transcranial direct current stimulation; MMQ, Multifactorial Memory Questionnaire; MST, mnemonic strategy training.

object), thereby reducing reliance on familiarity and
increasing reliance on recollection of the actual association.
Key features and dependent variables for these tasks are
listed subsequently. These measures are collected during
the baseline/screening session, Session 6 (w60 minutes after
the end of training), and Session 8.
2.3.1. Face-name generalization task
Memory for each association is first assessed using cued
recall where the patient sees a face and is asked to recall the
name. Participants then complete the recognition phase in
which they select the correct name from three options. The
dependent variable is the number of correctly recalled or
selected names and analyses will focus on change from baseline.
2.3.2. Object-location touch screen test (see [40])
Memory is assessed under three unique conditions. Free
recall: First, participants see a target object followed by a
blank screen and are instructed to touch the location of the
object on a 19 in. ELO touch screen monitor (ELO Touch Solutions, Milpitas, CA, USA). Cued recall: Next, participants

see the object and then its associated room (without the object
present) and are instructed to touch its location. The primary
dependent variable for both of these conditions is the distance
(in centimeters) between the selected and target location. This
approach allows us to quantify the severity of memory failure
as opposed to relying on the traditional dichotomous view of
memory as correct or incorrect. Recognition: Finally, participants complete a recognition trial in which they select the
location of the object from three potential locations. Including
this trial allows us to place the results within the context of
traditional dichotomous views of memory. The dependent variable is the number of correctly selected locations. Analyses
will focus on change from baseline for each of these measures.
2.4. Secondary outcome measures
2.4.1. Multifactorial Memory Questionnaire [41]
This questionnaire is a self-report measure that was
developed to specifically assess dimensions of memory
that are applicable to clinical assessment and intervention.
Participants indicate the degree to which they agree with a
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statement along a 5-point scale. Three scales are provided:
(1) the Ability scale (20 items), which assesses self-report
of difficulty with everyday memory situations; (2) the
Contentment scale (18 items), which assesses the emotions
and perceptions that individuals have about their current
memory ability; and (3) the Strategy scale (19 items), which
examines the respondent’s use of memory aids and strategies. The Multifactorial Memory Questionnaire has strong
psychometric properties (see [41] for a full description)
and has been used in several intervention studies in both
healthy older adults [42] and MCI patients [43,44].
Dependent variables are the number of items endorsed on
each scale. Analyses will evaluate change from baseline.
2.4.2. Ecological memory simulations
Two subtests from the ecological memory simulations
[45,46] will be used to evaluate transfer effects. There are
two versions of each subtest, and we are using Form 1 at
baseline, Form 2 during the post-training evaluation (Session 6), and repeating Form 1 during the 3-month evaluation
(Session 8).
2.4.2.1. Route Recall Simulation
This simulation asks patients to learn and remember an
indoor route presented as a series of two- and three-choice
intersections where a model chooses to go left, right, or
straight an equal number of times. Memory for this route
is assessed immediately and after a 15-minute delay by
showing participants an intersection and asking them to
recall the direction in which the model traveled. Recall of
the route is assessed in both serial and random order. The
dependent variable is the number of turns correctly recalled.
Analyses will evaluate change from baseline. We included
this task as a measure of near transfer because the design
is amenable to mnemonic strategy use (e.g., identifying a
salient feature at each intersection, developing a reason linking that feature with the targeted direction—see description
of MST mentioned previously).
2.4.2.2. Medical instructions simulation
This simulation is a prose memory task in which the
patient is read medication instructions and then asked to
recall this information immediately, after a second presenta-
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tion of the instructions, and after a 15-minute delay. We
included this task as a measure of far transfer because the
task measures memory, yet the particular mnemonic strategies we teach are unlikely to help the patient process such
information. Thus, task improvement would be expected
because of general “strengthening” of the key frontoparietal
network as a result HD-tDCS. The dependent variable is the
amount of information recalled. Analyses will evaluate
change from baseline.
2.5. Session 1: fMRI scanning
Activation will be assessed using memory encoding,
working memory, and semantic processing paradigms.
Participants will complete scanning during Sessions 1, 7,
and 8. Although the study focuses on task-based fMRI,
resting-state data are collected at the start of each of these
sessions and will be interrogated for exploratory purposes.
2.5.1. Memory encoding
Because we are interested in the general network underlying successful MST use, participants complete functional
runs during which they encode novel stimuli from both the
face-name and object-location association paradigms.
Importantly, these stimuli are independent of those used
for our primary outcome measures. Two repeated stimuli
within each paradigm are presented multiple times and
will serve as the control condition. We reconfigured our
existing paradigms [10,25] to create three lists (Lists A, B,
and C) of 30 stimuli. As shown in Tables 1 and 2, these
lists are comparable on a number of key features. A
different list is used in Sessions 1, 7, and 8, thereby
mitigating stimulus-specific effects. We elected to hold the
list constant (i.e., List A in Session 1; List B in Session 7;
and List C in Session 8) so that only the treatment condition
differs between the groups.
Participants complete a total of four functional runs,
two in each condition (each 6 minutes, 20 seconds in duration). We selected a mixed event-related block design
based on simulation data because it maximized power
and provided optimal flexibility (e.g., retrospectively coding each stimulus as remembered vs. forgotten for an

Table 1
Properties of the face-name task used in fMRI

Popularity x (SD)*
Letters x (SD)y
Ethnicity
Minority
Mean rank
Gender
Male
Mean rank

SET A

SET B

SET C

F2,87

90.06 (129.63)
5.50 (0.51)

87.34 (107.09)
5.50 (0.51)

87.22 (86.91)
5.53 (0.51)

n 5 16
53.5

n 5 11
46

n 5 11
46

0.007, P 5 .993
0.040, P 5 .960
c2(2)
2.155, P 5 .34

n 5 14
50

n 5 15
48.5

n 5 16
47

*Popularity of ranking is based on Social Security data and assessed by approximate age (by decade) of face.
y
Number of letters in each name.

0.248, P 5 .88
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Table 2
Properties of the object-location task used in fMRI

Frequency*
Percentagey
Lettersz

List A x (SD)

List B x (SD)

List C (3) x (SD)

F2,87

49.62 (128.45)
9.99 (17.58)
5.63 (2.25)

20.86 (35.47)
6.71 (8.71)
6.10 (1.77)

37.66 (86.02)
9.32 (16.45)
5.70 (1.60)

0.747, P5 .477
0.412, P 5 .664
0.533, P 5 .589

*Frequency per million words based on corpus developed by Brysbaert and New (2009). Moving beyond Kucera and Francis: a critical evaluation of current
word frequency norms and the introduction of a new and improved word frequency measure for American English. Behavior Research Methods, 41(4), 977–
990.
y
Percentage of times word appears in a film (within the corpus).
z
Number of letters in the word.

event-related analysis). Each run consists of six active
blocks (three novel and three repeated stimuli) and seven
rest blocks (20 seconds each). During active blocks, five
stimuli are presented for 5 seconds each and are separated
by an interstimulus interval (ISI) of 1, 2, 3, 4, or 5 seconds.
The ISI was randomized so that the across-block average
within a given run was 15 seconds, which led to variability
in the length of individual active blocks (from 34 to 46 seconds). Participants are instructed to push a button with
their right index finger each time a new stimulus appears,
a requirement meant to ensure they are attending to the
task at hand. Run order is randomized for each patient.
The interaction contrast of list and time is of primary interest (Novel [post-training . pretraining] . Repeated [posttraining . pretraining]). We refer to this as the encoding
contrast hereafter. Exploratory analyses will evaluate activation changes within each paradigm individually (i.e.,
face-name or object-location). Participants complete a
memory test using these stimuli outside of the scanner.
2.5.2. Working memory and semantic processing
Participants complete a standard n-back working memory
paradigm. In the 0-back (control) condition, participants
push a button on an fMRI compatible response pad
using their right index finger when a target stimulus
appears. The 2-back condition requires participants to push
the button when a given stimulus was also seen two stimuli
ago. The primary contrast of interest examines the interaction between condition and time: (post-training [2back . 0-back] . pretraining [2-back . 0-back]). We refer
to this as the contrast for item working memory hereafter.
To evaluate whether MST or HD-tDCS also affects
semantic processing, we developed a semantic 2-back task
that requires participants to determine if a given stimulus
is of the same semantic category (e.g., an animal) as the
one presented two stimuli ago. Similar paradigms have
effectively engaged the left lateral PFC [47]. Using the
same n-back design holds all task demands constant except
for the addition of semantic processing. Thus, the primary
contrast of interest will subtract out blood oxygen level
dependent (BOLD) signal associated with working memory
from the semantic task via the interaction contrast of task
and time: (semantic [2-back post-training . 2-back
pretraining] . item [2-back post-training . 2-back pretrain-

ing]). We refer to this as the contrast for semantic processing
hereafter.
These paradigms allow us to directly examine the cognitive
processes and associated brain regions underlying mnemonic
strategy use (Aim 2) as well as any HD-tDCS–related
improvements in other cognitive abilities (Aim 3). In developing these tasks, we selected a total of 45 stimuli using color
versions of the classic Snodgrass and Vanderwart set (obtained
at http://spell.psychology.wustl.edu/Rossion_stimuli/) and,
specifically, five stimuli from each of nine semantic categories. We created three groups of 15 stimuli (three semantic
categories with five stimuli per category in each list) (Group 1:
body parts, animals, and furniture; Group 2: tools, fruits, and
clothing; Group 3: musical instruments, vegetables, and vehicles). These same three groups of stimuli are used in each scan
session to mitigate any stimulus-specific effects; however, the
stimuli used for a given cognitive task (0-back, 2-back, semantic 2-back) are rotated for each session. For example, group 1
could be used for 0-back during Session 1, 2-back for Session
7, and semantic 2-back for Session 8. Stimuli are presented
using a block design (4 minutes, 30 seconds) that consists of
five active and six (20 second) rest blocks. Within each 3000
active block, 15 stimuli are presented for 100 and separated
by a 100 ISI. Four to six target stimuli are shown in each active
block, a design meant to reduce predictability. Participants
respond by pushing a button with the right index finger.
2.5.3. MRI image acquisition
All imaging is performed using a 3 T GE Signa MRI with a
32-channel head coil. Stimuli are presented on a rear-mounted
liquid crystal display screen. High-resolution anatomic images
are acquired using a three-dimensional BRAVO sequence with
repetition time (TR) 12.2 ms, echo time (TE) 5.2 ms, inversion
time 500 ms, flip angle (FA) 15 , 160 sagittal slices of 1 mm
thickness, in-plane resolution (IPR) 1 ! 1 mm, in-plane matrix
(IPM) 256 ! 256, and field of view (FOV) 256 mm. All
fMRI data are collected using T2*-weighted functional images
acquired with a multiband slice accelerated gradient-recalled
echo planar imaging sequence with BOLD contrast
and the following parameters: resting-state scans: TR,
900 ms; TE, 30 ms; FOV, 240 mm; FA, 70 ; 45 axial slices
of 3 mm thickness; IPR, 3.0 ! 3.0 mm; IPM, 74 ! 74;
3.24 ! 3.24 ! 3 mm voxels. All task-related scans use the
following parameters: TR, 1200 ms; TE, 30 ms; FOV,
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220 mm; FA, 70 ; 51 axial slices of 2.5 mm thickness; IPR,
2.5 ! 2.5 mm; IPM, 88 ! 88; voxel size, 2.5 mm isotropic.
2.6. Interventions
Administered in Sessions 2 to 6.
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the next 60 to 110 minutes (the first 30 minutes are concurrent with HD-tDCS) and the final 10 minutes are used to
answer any questions and remove the HD-tDCS electrodes.
Participants are allowed to miss up to two training sessions
and still remain active in the study.

2.6.1. Randomization
During the consent process, participants are informed
that the study evaluates cognitively based interventions;
however, participants are not given specific information
about the interventions to keep them blinded to the alternative cognitive condition. Participants are also informed that
sham HD-tDCS may be used but are not told the difference
between active and sham parameters. All participants
receive a study ID that is used on all study materials (i.e.,
no personal identifiers are used). All data are double scored
and entered into a secure database to which only study team
has access.
A series of random 6-digit computer-generated codes
were created and preprogrammed into the Soterix Medical,
Inc Clinical Trial tDCS unit. We use the sealed envelope
method in which group assignment (i.e., the cognitive
training condition and the numeric code for the tDCS unit)
is placed within a sealed envelope at the beginning of the
study. This numeric code is participant unique and allows
for double blinding of HD-tDCS condition. A blocked
randomization schedule is used with 1:1:1:1 allocation to
each of the four groups that are run in parallel (i.e., active
HD-tDCS 1 MST, sham HD-tDCS 1 MST, active HDtDCS 1 ABR, or sham HD-tDCS 1 ABR). Soterix Medical
Inc generated the codes. The study principal investigator
(B.M.H.) generated the allocation sequence and shuffled
the sealed envelopes. Study staff enroll participants and
assign study conditions.
At the beginning of Session 2 (i.e., the first training
session), a study staff member opens the envelope, thereby
revealing the participant’s cognitive training group and
unique HD-tDCS code. Thus, participants are doubleblinded (i.e., to the other cognitive intervention and to
HD-tDCS status) and study staff are single-blinded (i.e., to
HD-tDCS status). A study team member who did not administer the intervention(s) performs the outcome evaluations. A
separate study team member who is double-blinded analyzes
first level fMRI data. Second-level fMRI analyses will be
performed at the end of the study after breaking the blind.
Unblinding will occur during the study period only if a
patient experiences an unexpected adverse event.

2.6.2.1. Mnemonic Strategy Training
A brief didactic period is provided during the first session in which the rationale and methods are explained.
MST begins at the same time as HD-tDCS stimulation
and persists for approximately 30 to 90 minutes after stimulation has ended. This approach intends to capitalize on
the neuroplastic changes induced by HD-tDCS and to
adaptively shape them using MST, thereby reinforcing
the interactions necessary for successful strategy use. Patients will use the same three-step process as in our prior
studies [19,23]. We refer to this process as “FRI”, for
feature (F), reason (R), and image (I). In the first step, a
salient feature is identified. Participants are encouraged
to select something that is especially unique or unusual
about the stimulus. Next, a verbally based reason for
selecting that specific feature is developed. This reason
should integrate the feature with the targeted information
(e.g., the name). Finally, participants imagine and
integrate these previous steps using mental imagery (i.e.,
by creating a mental “picture” or “movie”). On each
subsequent trial, we require participants to recall the
feature, the reason, the image, and then the targeted
information (e.g., the name) in that specific order. To
reinforce the use of the FRI approach, patients are given
nine trials per stimulus. This process is designed to
promote a specific series of steps that participants will
use when encountering information in the future, thereby
altering the manner in which they learn and recall
information. We previously discussed the benefits of a
trial-based format [20], which ensures comparable
exposure to the study methods relative to a session or
time-based design where individual sessions may differ
substantially both within and between participants. Participants are required to independently develop the feature,
reason, and image cues for each stimulus. A member of
our research team monitors and records each step of the
process to ensure compliance. We provide assistance and
model appropriate cues as needed to promote successful
strategy use. Participants practice this MST approach using
a total of 12 stimuli (six faces and names; six objects and
locations) in each session (108 trials per session; 540 total
trials across all sessions).

2.6.2. Intervention by group
All groups undergo five training sessions on consecutive
days. Each session lasts approximately 80 to 120 minutes
depending on the speed with which the patient completes
the training. The first 10 to 15 minutes of each session are
used to measure and place the HD-tDCS electrodes. The
cognitive intervention (i.e., MST or ABR) occurs during

2.6.2.2. Autobiographical memory recall
We selected ABR as an active control condition for MST
because it focuses on memory and engages patients in general conversation with our research team, thereby matching
nonspecific factors and total session time. This approach is
similar to reminiscence therapy, which has shown some positive effects in patients with AD [48] and, as a result, can be
considered an active comparator.
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This condition begins at the same time as HD-tDCS and
persists for approximately 30 to 90 minutes after stimulation
has ended. During each session, participants are asked to
identify and write a brief description of five emotionally positive memories from each of five distinct periods of life (Session 1, 0–15 years old; Session 2, 16–30 years old; Session 3,
31–45 years old; Session 4, 45 years old to 5 years ago; Session 5, last 5 years). Participants are then asked to describe
each memory in their own words. The entire session is audio
recorded for later transcription and analysis. After this free
recall period, our staff asks the participant to rate how
pleasant, significant, intense, novel, and vivid each memory
is using a 7-point scale (with anchored values; 1 being
lowest/worst and 7 being highest/best). Participants are also
asked how frequently they think about or recall the memory.
We then ask a series of questions that are meant to further
probe the episodic aspects of each memory including how
the participant felt during the event, what sights were around
them, what kind of smells they experienced, and why the
participant thinks they still recall the particular memory.
These questions are meant to ensure comparable engagement
and experience as with the MST group. In addition, however,
we intend to analyze the transcribed data for linguistic qualities by Linguistic Inquiry and Word Count or other related
methods. This approach may be especially informative given
that HD-tDCS is being performed over the left lateral PFC
(including “Broca’s area”), which is known to be vital for
speech production. Thus, it is possible that active HD-tDCS
versus sham HD-tDCS could facilitate speech output over
the course of the five sessions (this possibility will be evaluated in exploratory analyses). Such findings may be especially
powerful given evidence that MCI patients recall fewer
episodic details and use less complex language relative to
control subjects [49,50].
2.6.2.3. High definition transcranial direct current
stimulation
Stimulation is performed using a Soterix Medical Inc
tDCS unit (Clinical Trial system and connected 4 ! 1 HD
stimulation unit) within a quiet room. Fig. 2 shows our
HD-tDCS montage and finite element models of electrical
current flow (comparable results can be obtained using
HD-Explore software from Soterix Medical, Inc). As can
be seen, our montage selectively targets the left lateral
PFC, especially the inferior frontal sulcus and gyrus.

Participant-specific codes are entered and the unit automatically discontinues stimulation after the specified time has
elapsed, which is based on active versus sham grouping.
At the end of the session, participants complete a brief questionnaire about the nature and severity of any side effects, as
recommended by Brunoni et al. [51]. An independent tDCS
expert reviews safety and tolerability data on a biannual basis and submits findings to the institutional review board.
2.6.2.3.1. Active tDCS protocol
This protocol provides a 30-second ramp-up period in
which the electrical current is gradually increased, followed
by 29 minutes of stimulation at 2 mA, and finally a 30second ramp down period during which the electrical current
is gradually removed. This “dose” was based on two previous tDCS studies in patients with AD [52,53].
2.6.2.3.2. Sham tDCS protocol
This protocol follows standard designs [54] and provides a
30-second ramp-up period to the full 2 mA, followed immediately by a 30-second ramp down. We repeat this process during the final minute of the session to provide patients with both
“primacy” and “recency” experiences of stimulation. This is
an appropriate comparator for active HD-tDCS because it provides comparable sensory experiences absent the physiological effect, thereby resulting in effective blinding [28,31,51].

2.7. Session 7
Approximately 2 to 4 days after the final training session
(depending on participant and scanner availability), participants complete fMRI scanning using a novel list of stimuli
for each task (List B). Memory for the face-name and
object-locations is assessed outside the scanner as described
previously.

2.8. Session 8
Approximately 3 months after Session 7 (typically
67 days), participants return for a follow-up session. Primary and secondary outcome measures are collected. Participants are then escorted to the MRI scanner, where they
complete scanning using a novel list of stimuli for each
task (List C).

Fig. 2. Finite element models of electric current flow using our HD-tDCS montage. Abbreviation: HD-tDCS, high definition transcranial direct current stimulation.
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2.9. Power and statistical analysis
Previously published results [55] of neurostimulation
studies suggest mean cognitive effect sizes (in Cohen’s d)
of 0.42 for single sessions and 0.89 for multiple sessions
in healthy older adults and even larger effects in patients
with AD, ranges generally consonant with those recently
suggested for tDCS studies [56]. Our prior studies with
MST indicated large effect sizes (ph2 5 0.16) relative to
tightly matched active control conditions [21]. fMRI power
analysis is complex owing to the large number of potential
variables (and brain regions). Two independent studies
have recommended group sizes of 20 to 25 assuming a
0.5% BOLD signal change, 80% power, and a of 0.05 to
0.002 [57,58]. Fig. 3 (via G*Power 3.1, power 5 0.8,
a 5 0.05) shows the within-between interaction sensitivity
to effect sizes based on total sample size and indicates that
the present study will be sensitive to medium (f(V) w 0.4)
to large (f(V) w 0.5) effect size even with 20% attrition.
These same parameters yield sensitivity to medium
between-groups (f(V) 5 0.336) and within-groups
(f(V) 5 0.348) effect sizes.
To protect confidentiality, participants are assigned a
subject ID that is used for all materials. Only select team
members have access to the code. No identifiers are included
in study folders or digital files. Digital data are stored on a
secure server to which only select study team members
have access. Neuropsychological and outcome data are
collected by trained study team members, double scored,
and then entered into a secure database. Range checks and
double entry will be used to ensure data accuracy. MRI data
are transferred to a secure server and analyzed using an
“attached” virtual machine. The primary analytic technique
for behavioral data will be regression using the SAS mixed
procedure (PROC MIXED or another comparable approach),
which allows the interdependence of observations to be
modeled directly and can include subjects with missing data
at one of the follow-up periods. PROC MIXED has the capacity to handle unbalanced data when the data are missing
at random (skipped visits, patient dropout, and so forth),
although a large amount of missing data is considered
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unlikely because of the nature of the study and the efforts
that will be made to ensure consistent follow-up participation.
Each mixed linear model equation will model the change
from baseline for one of the outcome measures as a function
of intervention group, post-training session (i.e., Session 7 or
8), and group ! post-training session interaction. In addition,
all models may include potential confounders that differ at
baseline between the groups (at P 5 .05) even despite
randomization (there should be few, if any, given the sample
size). Results of primary and secondary outcome measures
will be considered significant if P  .05.
2.9.1. fMRI analyses
Given the anatomic specificity of our hypothesis, our
primary fMRI analyses will use a region of interest (ROI)
approach following the anatomic boundaries of the left
ventrolateral PFC. After single-session preprocessing, we
will calculate voxelwise area under the curve in which the
hemodynamic response is averaged across all voxels and
time points for the previously described contrasts during
each of the fMRI session (Sessions 1, 7, and 8). This has
the benefit of providing a single value for each group in
each session, thereby substantially reducing the number of
contrasts and increasing power. We will examine the ROIbased data using the same PROC MIXED (or related)
procedures. Exploratory whole brain analyses will also be
performed to evaluate treatment-induced changes that would
suggest compensatory and/or restorative mechanisms. Connectivity analyses will be performed using the ROI as the
seed area. We will then correlate the change in activation
for both the immediate and long-term effects with the corresponding average change in behavioral performance on our
primary outcome measures of the object-location touch
screen test and face-name generalization task. These behavioral measures are completely independent of the fMRI data
and, therefore, will provide an unbiased measure of the relationship between these variables. Exploratory behavioral
and fMRI analyses for the working memory and semantic
processing tasks will follow the aforementioned analytic
plan.

Fig. 3. Sensitivity (80% power) to effect size (y-axis) by total sample size (x-axis) for the present study (figure provided by G*Power 3.1).
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3. Discussion

Acknowledgments

This ongoing double-blind, randomized controlled trial
with four parallel groups evaluates the behavioral and neurophysiological changes associated with MST and HD-tDCS
in patients with MCI. As discussed previously, prior research
indicated that MST enhanced long-term retention of new information but that these benefits were attenuated in more
advanced patients. In addition, patients have difficulty spontaneously transferring MST to new types of information—a limitation that makes this type of training task-specific. HD-tDCS
was included a method that may enhance functioning on its
own, facilitate the acquisition and long-term use of MST,
and, perhaps, increase the range of patients who benefit from
MST. This approach builds on prior evidence from the motor
literature that stimulation may enhance and/or prolong effects
of behavioral training [32]. Thus, the difference in outcome
measures in Session 6/7 (post-treatment) relative to baseline
will provide evidence of near-term efficacy, whereas the difference between post-training and the 3-month follow-up
will provide vital information about the persistence of changes
and inform the timing of any necessary booster sessions.
Several methodological challenges exist with this type of
study and we have adopted a number of procedures to proactively deal with such issues. First, we use a range of methods to
enhance retention including didactics about why dropout is so
detrimental to longitudinal research, encouraging participants
to take part only if they are certain they will complete the
study, and providing session reminders (via participant’s
preferred method of contact). Second, scheduling is tailored
to the participants’ availability, thereby minimizing conflicts.
Third, additional travel funds were allocated to ensure equal
access for all interested and eligible participants. Fourth, participants are allowed to take part in all standard clinical care
activities. Importantly, however, there are no cognitive or
physically based clinical programs for those with MCI that
could confound results in the geographical region. Participants are required to be stable on medications for at least
4 weeks before the study and are asked not to alter their medications, unless recommended by their physician, until the end
of the study. Any changes in medications or other health conditions are recorded at the time of the next study visit.
Our outcome measures were designed to be ecologically
relevant to enhance participant motivation and transfer to
everyday life. Although group-level effects are important,
the study will yield rich clinical and neuroanatomic data
that will be used to identify individual patient factors that
affect treatment response. Such factors include cognitive
functioning (e.g., scores on standardized neuropsychological testing) as well as the structural (e.g., brain volume/
cortical thickness) and functional integrity of the brain at
baseline (e.g., resting-state functional connectivity).
Together, we expect our findings will provide critical information about these nonpharmacologic approaches that will
guide future research and, ideally, meaningfully inform clinical practice in this growing population.
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RESEARCH IN CONTEXT

1. Systematic review: Previous studies have demonstrated that mnemonic strategy training can (re)
engage key lateral frontoparietal and medial temporal regions thereby enhancing learning and memory,
at least under some conditions. It is unclear whether
forms of noninvasive brain stimulation can enhance
and prolong this effect, thereby improving subjective
and objective memory performance in those with
memory impairment.
2. Interpretation: The results of the intervention(s)
described in this protocol will (1) extend our understanding of the conditions under which cognitively oriented treatments are effective, especially
in respect to the transfer of trained skills and (2)
evaluate the independent and synergistic effects
of noninvasive brain stimulation on learning and
memory.
3. Future directions: Study results will identify the
extent, magnitude, and persistence of change in
memory-related abilities as well as participantspecific predictors of response, thereby enhancing
future trial design and facilitating the clinical translation of such methods.
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